Product NDC: | 55289-954 |
Proprietary Name: | SUPRAX |
Non Proprietary Name: | CEFIXIME |
Active Ingredient(s): | 400 mg/1 & nbsp; CEFIXIME |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55289-954 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065130 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080401 |
Package NDC: | 55289-954-79 |
Package Description: | 1 TABLET in 1 BOTTLE, PLASTIC (55289-954-79) |
NDC Code | 55289-954-79 |
Proprietary Name | SUPRAX |
Package Description | 1 TABLET in 1 BOTTLE, PLASTIC (55289-954-79) |
Product NDC | 55289-954 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CEFIXIME |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080401 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | CEFIXIME |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |